Royal Prima PT (PRIM) - Total Liabilities

Latest as of September 2025: Rp111.14 Billion IDR ≈ $6.51 Million USD

Based on the latest financial reports, Royal Prima PT (PRIM) has total liabilities worth Rp111.14 Billion IDR (≈ $6.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Royal Prima PT equity growth rate to track the company's year-over-year net asset growth rate.

Royal Prima PT - Total Liabilities Trend (2014–2024)

This chart illustrates how Royal Prima PT's total liabilities have evolved over time, based on quarterly financial data. See PRIM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Royal Prima PT Competitors by Total Liabilities

The table below lists competitors of Royal Prima PT ranked by their total liabilities.

Company Country Total Liabilities
Kumbi Corporation
KO:008870
Korea ₩158.32 Billion
Resverlogix Corp.
TO:RVX
Canada CA$98.31 Million
Magna Finance Tbk
JK:MGNA
Indonesia Rp89.47 Billion
Diamond Citra Propertindo PT
JK:DADA
Indonesia Rp285.24 Billion
Cherrybro co.Ltd
KQ:066360
Korea ₩188.30 Billion
Daishin Information & Communications Co.Ltd
KQ:020180
Korea ₩116.84 Billion
Victor Group Holdings Ltd
AU:VIG
Australia AU$6.95 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Royal Prima PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Royal Prima PT market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.05 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Royal Prima PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Royal Prima PT (2014–2024)

The table below shows the annual total liabilities of Royal Prima PT from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 Rp122.17 Billion
≈ $7.16 Million
+145.89%
2023-12-31 Rp49.69 Billion
≈ $2.91 Million
-4.20%
2022-12-31 Rp51.86 Billion
≈ $3.04 Million
-68.97%
2021-12-31 Rp167.11 Billion
≈ $9.79 Million
+174.17%
2020-12-31 Rp60.95 Billion
≈ $3.57 Million
+0.95%
2019-12-31 Rp60.38 Billion
≈ $3.54 Million
-4.81%
2018-12-31 Rp63.43 Billion
≈ $3.72 Million
+7.11%
2017-12-31 Rp59.22 Billion
≈ $3.47 Million
+126.60%
2016-12-31 Rp26.13 Billion
≈ $1.53 Million
-0.95%
2015-12-31 Rp26.38 Billion
≈ $1.55 Million
+89.58%
2014-12-31 Rp13.92 Billion
≈ $815.50K
--

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$21.78 Million
Rp371.62 Billion IDR
Market Cap Rank
#24829 Global
#523 in Indonesia
Share Price
Rp110.00
Change (1 day)
-2.65%
52-Week Range
Rp62.00 - Rp113.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more